Delivery Order SPE2DB20D3101-SPE2DB25FREJ6
Award Date
3/13/25
Potential Completion Date
3/14/25
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,531.52 and an ultimate completion date of March 17, 2025. It is a delivery order contract for the supply of pharmaceutical products, including AZSTARYS capsules, with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,096.07, is a firm fixed-price delivery order for AZSTARYS CAPS 52.3MG/10.4MG. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The award, valued at $4,893.00, is a Firm Fixed Price Delivery Order contract for the pharmaceutical product AZSTARYS 26.1 MG-5.2 MG CAP 100S. The contract has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024 with a ceiling value of $2,057.50. It is a firm fixed-price delivery order contract with a completion date of December 10, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a prescription medication. The contract has a ceiling value of $1,156.16 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,035.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a prescription medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL13F, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $7,080.02 and an ultimate completion date of January 9, 2025. The contract is not designated with a set-aside, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, identified as SPE2DB22D1106|SPE2DB25FEAZ5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order valued at $1,640.49 for the supply of AZTREONAM 2 GM VIALS. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $905,408.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and it has an ultimate completion date of January 6, 2025. The contract does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products. The contract, valued at $1,053.76, is a Delivery Order with a Firm Fixed Price pricing type. The award has an ultimate completion date of July 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, will provide the DLA with the product "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML". This contract is not designated...